Over the past two years, malaria has become a vaccine-preventable disease thanks to the approval of two innovative vaccines.
The World Health Organization (WHO) now recommends that children in certain areas receive four doses of GSK's Mosquirix™ (RTS,S/AS01) malaria vaccine, the world's first approved malaria vaccine.
As of May 2024, Mosquirix is available in African countries but not in the United States.
How Many Malaria Vaccinations Are Needed
Proactive Vaccinology Builds Vaccines Before Pathogens Emerge
Unlike conventional vaccines that include a single antigen to train the immune system to target a specific virus, scientists say they have created a vaccine that protects against various coronaviruses, including potential future variants.
This 'Proactive Vaccinology' may protect people against a diverse range of existing coronaviruses or newly emerging pathogens.